BySally Beck July 17, 2023 READ

SINCE April 23, 2020, I have had 117 exchanges with our drugs watchdog, the Medicines and Healthcare products Regulatory Agency, about Covid-19 vaccines. Some were press releases letting me know the latest news on vaccine developments, others were emails from me to their press office desperately trying to find vital information on their protocols for adverse drug reactions. Most of the MHRA’s responses were politically correct, often vague, while some questions proved too awkward to answer.